BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8760303)

  • 1. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
    Wadman IA; Hsu HL; Cobb MH; Baer R
    Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of selected bHLH proteins by eHAND.
    Bounpheng MA; Morrish TA; Dodds SG; Christy BA
    Exp Cell Res; 2000 Jun; 257(2):320-31. PubMed ID: 10837146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
    Beltran AC; Dawson PE; Gottesfeld JM
    Chembiochem; 2005 Jan; 6(1):104-13. PubMed ID: 15593070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the basic helix-loop-helix protein ITF2 in the hormonal regulation of Sertoli cell differentiation.
    Muir T; Sadler-Riggleman I; Stevens JD; Skinner MK
    Mol Reprod Dev; 2006 Apr; 73(4):491-500. PubMed ID: 16425294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
    Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
    Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen.
    Hwang LY; Siegelman M; Davis L; Oppenheimer-Marks N; Baer R
    Oncogene; 1993 Nov; 8(11):3043-6. PubMed ID: 8414504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
    Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
    Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation.
    Postigo AA; Dean DC
    EMBO J; 1997 Jul; 16(13):3935-43. PubMed ID: 9233803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.